These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 19846853)

  • 21. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.
    Wilson C; Torpey N; Jaques B; Strain L; Talbot D; Manas D; Goodship T
    Am J Kidney Dis; 2011 Jul; 58(1):109-12. PubMed ID: 21601332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
    Dragon-Durey MA; Frémeaux-Bacchi V
    Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical HUS and complement dysregulation.
    Goodship TH
    J Am Soc Nephrol; 2006 Jul; 17(7):1775-6. PubMed ID: 16790505
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of complement in AMD.
    Zipfel PF; Lauer N; Skerka C
    Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
    Józsi M; Reuter S; Nozal P; López-Trascasa M; Sánchez-Corral P; Prohászka Z; Uzonyi B
    Immunol Lett; 2014 Aug; 160(2):163-71. PubMed ID: 24491679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.
    Dragon-Durey MA; Blanc C; Garnier A; Hofer J; Sethi SK; Zimmerhackl LB
    Semin Thromb Hemost; 2010 Sep; 36(6):633-40. PubMed ID: 20865640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
    Köse O; Zimmerhackl LB; Jungraithmayr T; Mache C; Nürnberger J
    Semin Thromb Hemost; 2010 Sep; 36(6):669-72. PubMed ID: 20865644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hemolytic uremic syndromes.
    Caprioli J; Peng L; Remuzzi G
    Curr Opin Crit Care; 2005 Oct; 11(5):487-92. PubMed ID: 16175037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-C5 as prophylactic therapy in atypical hemolytic uremic syndrome in living-related kidney transplantation.
    Pelicano MB; de Córdoba SR; Diekmann F; Saiz M; Herrero S; Oppenheimer F; Campistol JM
    Transplantation; 2013 Aug; 96(4):e26-9. PubMed ID: 23958887
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS).
    Roumenina LT; Roquigny R; Blanc C; Poulain N; Ngo S; Dragon-Durey MA; Frémeaux-Bacchi V
    Methods Mol Biol; 2014; 1100():237-47. PubMed ID: 24218264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
    Saland JM; Ruggenenti P; Remuzzi G;
    J Am Soc Nephrol; 2009 May; 20(5):940-9. PubMed ID: 19092117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.
    Sánchez-Corral P; González-Rubio C; Rodríguez de Córdoba S; López-Trascasa M
    Mol Immunol; 2004 May; 41(1):81-4. PubMed ID: 15140578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-nonself discrimination by the complement system.
    Meri S
    FEBS Lett; 2016 Aug; 590(15):2418-34. PubMed ID: 27393384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
    Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement dysregulation in haemolytic uraemic syndrome.
    Bonnardeaux A; Pichette V
    Lancet; 2003 Nov; 362(9395):1514-5. PubMed ID: 14615103
    [No Abstract]   [Full Text] [Related]  

  • 38. Eculizumab for atypical hemolytic-uremic syndrome.
    Nürnberger J; Philipp T; Witzke O; Opazo Saez A; Vester U; Baba HA; Kribben A; Zimmerhackl LB; Janecke AR; Nagel M; Kirschfink M
    N Engl J Med; 2009 Jan; 360(5):542-4. PubMed ID: 19179328
    [No Abstract]   [Full Text] [Related]  

  • 39. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
    Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atypical hemolytic uremic syndrome].
    Fujimura Y
    Rinsho Ketsueki; 2013 Oct; 54(10):1897-906. PubMed ID: 24064841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.